At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 35 enrolled
Drug / intervention
Pred-Gati-Brom +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lessdrops™ Prophylactic Treatment After Routine Phacoemulsification Compared to Standard Drops Regimen
In Brief
A Phase 4 clinical trial evaluating Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, and 2 other interventions for Cataract. Completed, enrolled 35 participants across 1 site.
Detailed Summary
To compare the use of a compounded eye drop containing an antibiotic, a non-steroidal and steroidal anti-inflammatory to standard of care that is the use of 3 different topical medications to prevent inflammation and infection after routine cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsScience in Vision, Imprimis Pharmaceuticals, Inc.
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJul 2018
Primary CompletionDec 2019
TodayJul 2026
First PostedJul 6, 2018
Enrollment StartJun 22, 2018
Primary CompletionDec 4, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.0 years ago
Interventions
Pred-Gati-Bromdrug
The combination drop therapy containing prednisolone acetate 1%, gatifloxacin 0.5%, and bromfenac 0.075%
Prednisolone acetate 1% ophthalmic suspensiondrug
Steroidal anti-inflammatory
Gatifloxacin Ophthalmicdrug
Antibiotic
Bromfenac 0.075% Oph Solutiondrug
Non-steroidal anti-inflammatory